Results 81 to 90 of about 30,378 (204)

A Clinical Guidance for the Management of Patients With Hepatoid Adenocarcinoma and A Case Series

open access: yesCancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Hepatoid adenocarcinoma (HAC) is a rare extrahepatic tumor of non‐germ cell origin that morphologically resembles hepatocellular carcinoma (HCC). HAC has a propensity to metastasize to the liver and therefore may be mistaken for HCC. There is a lack of standardized treatment protocols, and further studies are needed to evaluate the benefit of ...
Christina Liava   +4 more
wiley   +1 more source

Bilateral Neck Dissection Effectively Improves Prognosis of Patients With T3N0M0 Glottic Carcinoma

open access: yesCancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Background To evaluate the effect of bilateral elective node dissection on the prognosis of patients with T3N0M0 glottic carcinoma. Methods This retrospective cohort study enrolled two cohorts: patients screened from the Surveillance, Epidemiology, and End Results (SEER) database of the National Cancer Institute, and those treated at the First
Bixue Huang   +7 more
wiley   +1 more source

Effect of neiguan acupoint pressure on improving chemotherapy⁃induced nausea and vomiting in cancer patients:a Meta analysis

open access: yesHuli yanjiu, 2020
ObjectiveTo systematically evaluate the clinical effect of neiguan acupoint pressure on improving chemotherapy-induced nausea and vomiting in cancer patients.MethodThe RCTs related to effect of neiguan acupoint pressure on improving chemotherapy-induced ...
CHEN Feng   +4 more
doaj  

Continuing Immunotherapy Beyond Progression Prolongs the Survival of Patients With Extensive‐Stage Small‐Cell Lung Cancer: A Multicenter Retrospective Analysis

open access: yesCancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Background Platinum‐based two‐agent chemotherapy combined with immunotherapy is now the first‐line standard of care for extensive‐stage small cell lung cancer (ES‐SCLC). Further studies are needed to determine whether continuing immunotherapy (IO) can provide benefit in patients whose disease has progressed after first‐line treatment ...
Zhuoran Sun   +5 more
wiley   +1 more source

Fractionated Gamma Knife Radiation for Papillary Tumor of the Pineal Region: A Case Report and Literature Review

open access: yesClinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Papillary tumor of the pineal region (PTPR) is a rare central nervous system neoplasm with an unpredictable clinical course. Gross total resection, the preferred treatment, is often unachievable due to the tumor's deep‐seated location, necessitating alternative therapies.
Arad Iranmehr   +6 more
wiley   +1 more source

Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics

open access: yesCancer Management and Research, 2016
Megan Brafford May,1 Ashley E Glode2 1Department of Pharmacy, Baptist Health Lexington, Lexington, KY, USA; 2Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus ...
May MB, Glode AE
doaj  

Uremic Paralytic Ileus in a 70 Years Old Female: A Diagnostic Dilemma

open access: yesClinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Uremia has been associated with slowed intestinal motility, resulting in loss of peristalsis and the development of paralytic ileus. We present a case of uremia‐induced paralytic ileus in a 70‐year‐old woman. The patient was admitted with a 7‐day history of abdominal pain, vomiting, and constipation.
Ali Gohar   +7 more
wiley   +1 more source

A global review of acupuncture and moxibustion recommendations in guidelines/expert consensus for chemotherapy- and/or radiotherapy-induced nausea and/or vomiting

open access: yesWorld Journal of Acupuncture - Moxibustion
Objective: To summarize and analyze the recommendations of acupuncture and moxibustion in the global guidelines/expert consensus of chemotherapy- and/or radiotherapy-induced nausea and/or vomiting, providing a basis for the development of clinical ...
Tian-yu MING   +10 more
doaj   +1 more source

The safety of trastuzumab deruxtecan (T‐DXd) in breast cancer brain metastases with a focus on interstitial lung disease/pneumonitis: A systematic review and meta‐analysis

open access: yesCancer, Volume 132, Issue 3, 1 February 2026.
Abstract Background Although trastuzumab deruxtecan (T‐DXd) demonstrated unprecedented intracranial efficacy in HER2‐positive breast cancer brain metastases (BCBM), its association with interstitial lung disease (ILD)/pneumonitis posed a critical safety concern in this high‐risk population.
Yiwen Ma   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy